Ravi Kalhan, MD, MS
Disclosures: Speakers Bureau-Current-GlaxoSmithKline|Consulting Fee-ended 3/25/19-GlaxoSmithKline|Consulting Fee-current-CVS Caremark|Consulting Fee-ended 4/29/19-Boston Consulting Group|Speakers Bureau-current-AstraZeneca
No Bio Available.